☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Asia
Innovent and Lilly Report Results of Tyvyt (sintilimab) in Seven Clinical Studies to be Presented at the ESMO ASIA Congress 2020
November 5, 2020
World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan
August 31, 2020
Bayer and MassBio to Launch Joint Mentoring Program to Foster Startups in Asia
June 16, 2020
Alvotech Signs an Exclusive License Agreement with DKSH for AVT02 (biosimilar- adalimumab) in Asia
March 25, 2020
Alopexx Signs an Exclusive License Agreement with Shenogen Pharma to Develop and Commercialize DI-LEU16-IL2 for B-Cell Lymphomas i...
March 5, 2020
Daiichi Sankyo Acquires Rights for Astellas' Three Therapies to Boost its Presence in Asia
October 16, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.